AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy. (2021)
Attributed to:
Targeting the cellular metabolism to treat tissue-specific mitochondrial diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.65942
Publication URI: https://www.repository.cam.ac.uk/handle/1810/318824
Type: Journal Article/Review